Generation Bio Co. (GBIO)

$4.61 +0.41 (9.76%)
Market Cap 30.90M
Revenue (ttm) 19.89M
Net Income (ttm) -131.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -661.99%
Debt to Equity Ratio 0.00
Volume 181,200
Avg Vol 130,985
Day's Range N/A - N/A
Shares Out 6.70M
Stochastic %K 38%
Beta 2.59
Analysts Strong Sell
Price Target $70.00

Company Profile

Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-dri...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 655 7500
Address:
301 Binney Street, Cambridge, United States
Wilder992001
Wilder992001 Jul. 26 at 11:23 AM
$GBIO next week should be interesting.
2 · Reply
Whiskey1679
Whiskey1679 Jul. 25 at 11:38 PM
See my Profile Pinned Post for todays Winners!! Trending: $MVST $DRUG $TPST $HCTI $GBIO
0 · Reply
Diamondhandsjames52
Diamondhandsjames52 Jul. 25 at 10:00 PM
$TLIH $HCTI $GBIO $GSIW bulls $TLIH has 96 watchers this will explode when ppl do their Dd I’m grabbing these like pac man
0 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 7:47 PM
$GIBO I can’t even get the stock name right guys sorry this not $GBIO
0 · Reply
Diamondhandsjames52
Diamondhandsjames52 Jul. 25 at 7:43 PM
$TGL $GSIW $GBIO man I sold $ORIS fuck that I load $TGL its primed for massive run check it out bulls
1 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:43 PM
$GBIO JUST BROKE ALERTS 🔥🔥🔥🏌🏽‍♂️
0 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:36 PM
$GBIO 🏌🏽‍♂️ $CREV 🏌🏽‍♂️ $ANTF 🏌🏽‍♂️ Best swings ⚡️⚡️⚡️
0 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:10 PM
$GBIO ⚡️ $NVNI $VSTM $CREV⚡️ $ATNF ⚡️ That’s all for now watch these
1 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:08 PM
$GBIO going krazy from other day !
0 · Reply
LabPsycho
LabPsycho Jul. 25 at 5:01 PM
$IMNN See below...in only 1 day, already almost 1/2 of of the predicted additional post R/S drop. Frankly, the order I would guess that would be the best gamble for a bounce buying in November if they drop another 30-50% from here and selling in January would be $MRSN > $GBIO > $IMNN . Its all just a wild / lucky / unlucky gamble.
2 · Reply
Latest News on GBIO
Generation Bio Announces 1-for-10 Reverse Stock Split

Jul 18, 2025, 8:35 AM EDT - 9 days ago

Generation Bio Announces 1-for-10 Reverse Stock Split

Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Jul 7, 2025, 4:05 PM EDT - 20 days ago

Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

May 28, 2025, 6:59 AM EDT - 2 months ago

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 2 months ago

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

Apr 2, 2025, 6:59 AM EDT - 4 months ago

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Mar 13, 2025, 4:05 PM EDT - 4 months ago

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference

Feb 24, 2025, 6:59 AM EST - 5 months ago

Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference

Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.

Feb 6, 2025, 5:00 AM EST - 6 months ago

Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

Jan 6, 2025, 4:30 PM EST - 7 months ago

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

Oct 22, 2024, 6:59 AM EDT - 9 months ago

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

Sep 12, 2024, 4:05 PM EDT - 11 months ago

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

Aug 6, 2024, 6:59 AM EDT - 1 year ago

Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

Jun 14, 2024, 6:59 AM EDT - 1 year ago

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

May 13, 2024, 4:05 PM EDT - 1 year ago

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

May 9, 2024, 6:59 AM EDT - 1 year ago

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Apr 22, 2024, 5:31 PM EDT - 1 year ago

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

Apr 2, 2024, 6:59 AM EDT - 1 year ago

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Mar 6, 2024, 4:20 PM EST - 1 year ago

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

Feb 27, 2024, 6:59 AM EST - 1 year ago

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 3, 2024, 4:05 PM EST - 1 year ago

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

Nov 29, 2023, 6:59 AM EST - 1 year ago

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

Nov 9, 2023, 4:15 PM EST - 1 year ago

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

Oct 26, 2023, 6:59 AM EDT - 1 year ago

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO)

Oct 20, 2023, 8:15 AM EDT - 1 year ago

Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO)

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

Oct 18, 2023, 6:59 AM EDT - 1 year ago

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

Sep 19, 2023, 7:30 AM EDT - 2 years ago

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference

Generation Bio Reports Second Quarter 2023 Financial Results

Aug 2, 2023, 4:15 PM EDT - 2 years ago

Generation Bio Reports Second Quarter 2023 Financial Results

Generation Bio to Present at the 2023 Jefferies Healthcare Conference

May 31, 2023, 7:30 AM EDT - 2 years ago

Generation Bio to Present at the 2023 Jefferies Healthcare Conference

Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results

May 10, 2023, 4:15 PM EDT - 2 years ago

Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results

Generation Bio to Present at the JMP Securities Life Sciences Conference

May 9, 2023, 4:15 PM EDT - 2 years ago

Generation Bio to Present at the JMP Securities Life Sciences Conference

Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference

Apr 11, 2023, 7:30 AM EDT - 2 years ago

Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference

Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer

Apr 5, 2023, 7:30 AM EDT - 2 years ago

Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer

Generation Bio, Moderna announce collaboration

Mar 23, 2023, 7:44 AM EDT - 2 years ago

Generation Bio, Moderna announce collaboration

MRNA

Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines

Mar 23, 2023, 7:02 AM EDT - 2 years ago

Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines

MRNA

Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines

Mar 21, 2023, 4:15 PM EDT - 2 years ago

Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines

Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference

Feb 27, 2023, 7:30 AM EST - 2 years ago

Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference

Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 23, 2023, 4:28 PM EST - 2 years ago

Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results

Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

Jan 3, 2023, 4:30 PM EST - 2 years ago

Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results

Nov 3, 2022, 4:15 PM EDT - 2 years ago

Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results

Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit

Sep 22, 2022, 7:30 AM EDT - 3 years ago

Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit

Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer

Sep 20, 2022, 7:30 AM EDT - 3 years ago

Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer

Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results

Aug 4, 2022, 4:15 PM EDT - 3 years ago

Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results

Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

Aug 2, 2022, 4:15 PM EDT - 3 years ago

Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

Generation Bio Appoints Dannielle Appelhans to Its Board of Directors

Jul 18, 2022, 7:30 AM EDT - 3 years ago

Generation Bio Appoints Dannielle Appelhans to Its Board of Directors

Generation Bio to Present at the 2022 Jefferies Healthcare Conference

Jun 2, 2022, 7:30 AM EDT - 3 years ago

Generation Bio to Present at the 2022 Jefferies Healthcare Conference

Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results

May 5, 2022, 4:15 PM EDT - 3 years ago

Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results

Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference

Apr 5, 2022, 7:30 AM EDT - 3 years ago

Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference

Generation Bio to Participate in 42nd Annual Cowen Health Care Conference

Mar 2, 2022, 7:30 AM EST - 3 years ago

Generation Bio to Participate in 42nd Annual Cowen Health Care Conference

Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results

Feb 24, 2022, 4:20 PM EST - 3 years ago

Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results

Wilder992001
Wilder992001 Jul. 26 at 11:23 AM
$GBIO next week should be interesting.
2 · Reply
Whiskey1679
Whiskey1679 Jul. 25 at 11:38 PM
See my Profile Pinned Post for todays Winners!! Trending: $MVST $DRUG $TPST $HCTI $GBIO
0 · Reply
Diamondhandsjames52
Diamondhandsjames52 Jul. 25 at 10:00 PM
$TLIH $HCTI $GBIO $GSIW bulls $TLIH has 96 watchers this will explode when ppl do their Dd I’m grabbing these like pac man
0 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 7:47 PM
$GIBO I can’t even get the stock name right guys sorry this not $GBIO
0 · Reply
Diamondhandsjames52
Diamondhandsjames52 Jul. 25 at 7:43 PM
$TGL $GSIW $GBIO man I sold $ORIS fuck that I load $TGL its primed for massive run check it out bulls
1 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:43 PM
$GBIO JUST BROKE ALERTS 🔥🔥🔥🏌🏽‍♂️
0 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:36 PM
$GBIO 🏌🏽‍♂️ $CREV 🏌🏽‍♂️ $ANTF 🏌🏽‍♂️ Best swings ⚡️⚡️⚡️
0 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:10 PM
$GBIO ⚡️ $NVNI $VSTM $CREV⚡️ $ATNF ⚡️ That’s all for now watch these
1 · Reply
InstinctInvestor
InstinctInvestor Jul. 25 at 5:08 PM
$GBIO going krazy from other day !
0 · Reply
LabPsycho
LabPsycho Jul. 25 at 5:01 PM
$IMNN See below...in only 1 day, already almost 1/2 of of the predicted additional post R/S drop. Frankly, the order I would guess that would be the best gamble for a bounce buying in November if they drop another 30-50% from here and selling in January would be $MRSN > $GBIO > $IMNN . Its all just a wild / lucky / unlucky gamble.
2 · Reply
AlTryToTrade
AlTryToTrade Jul. 25 at 4:53 PM
$GBIO 👀👀
0 · Reply
MKRReformed
MKRReformed Jul. 25 at 4:53 PM
$GBIO two month hold
3 · Reply
AzizAzizJ1
AzizAzizJ1 Jul. 25 at 4:38 PM
$GBIO hı
0 · Reply
makedatbread88
makedatbread88 Jul. 25 at 4:25 PM
$GBIO SUCH A MAJOR BUY ANYTHING UNDER $5!!!
1 · Reply
Diamondhandsjames52
Diamondhandsjames52 Jul. 25 at 3:47 PM
$LHAI $GBIO yes I’m still holding $LHAI waiting on the run I don’t think it’s over just getting started
1 · Reply
Rony4AM
Rony4AM Jul. 25 at 3:35 PM
$GBIO - $MRSN
1 · Reply
PatentGrants
PatentGrants Jul. 24 at 7:56 PM
$GBIO Generation Bio has been granted Australian patent number 2019210034 titled "Closed-ended DNA vectors obtainable from cell-free synthesis and process for obtaining ceDNA vectors (for gene therapy)". https://ipsearch.ipaustralia.gov.au/patents/2019210034
0 · Reply
sixmilliondollarman
sixmilliondollarman Jul. 24 at 7:13 PM
$GBIO I know some here fear manipulation but actually the manipulation to the downside will be small and designed to make holding appear sketchy. The big manipulation will be to the upside. Atlas (VC backers) and other strong institutional holders plus insiders need a liquidity event. Believe me they will engineer it! Up big soon! Mark it
0 · Reply
makedatbread88
makedatbread88 Jul. 24 at 7:08 PM
$GBIO 💰💰💰MAJOR BUY 💰💰💰💰 Loading all I can under $4.50 so undervalued read 👇👇👇👇
0 · Reply
sixmilliondollarman
sixmilliondollarman Jul. 24 at 4:19 PM
$GBIO one more gem for today. Jason Rhodes, GBIO co founder & chairman, was also founding CEO of Dyne Therapeutics (DYN) and head of BD at Alnylam (ALNY). Phillip Samayoa, our chief science officer and co founder also co founded DYN. Our CFO comes from ALNY and our head of business development comes from ALNY. I mention these things because both ALNY and DYN pioneered and advanced siRNA. And now GBIO is advancing siRNA and ctLNP to deliver it! Know what you own!
1 · Reply
sixmilliondollarman
sixmilliondollarman Jul. 24 at 3:57 PM
$GBIO can for the first time ever with ctLNP platform technology and proven siRNA technology drug the undruggable in T cell driven autoimmune diseases with no off target effects and bypassing the liver and spleen. What GBIO is doing is groundbreaking! Validated by the $1.8B Moderna deal and 8.7% stake they took in GBIO. Moderna has the right to option 3 different programs and they are funding all R&D. Just sayin 🤷‍♂️
0 · Reply
Navadel_
Navadel_ Jul. 24 at 3:41 PM
$GBIO it is blatantly obvious that zero news pushed this up from weeks of stagnation a day before the announcement. We are not in the know. We are not in the inner circle.
0 · Reply